CD34 and myelodysplastic syndrome: In fact, the PARPi caused a reduction of CD117+ or CD34+ hematopoietic progenitors and an increase in maturing CD11b+/CD16+ and CD10+/CD15+ cells in almost all MDS analyzed samples.